Welcome to our dedicated page for Advanced Flower Capital SEC filings (Ticker: AFCG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings for Advanced Flower Capital Inc. (Nasdaq: AFCG) provide detailed insight into the company’s evolution from a commercial mortgage real estate investment trust to a business development company (BDC) and its ongoing lending activities. As a Maryland corporation based in West Palm Beach, Florida, Advanced Flower Capital files periodic and current reports that describe its loan portfolio, capital structure, governance arrangements and regulatory status.
Through this page, investors can review annual reports on Form 10-K and quarterly reports on Form 10-Q, which typically include information on GAAP net income or loss, the composition and performance of the loan portfolio, credit loss provisions, and the company’s non-GAAP measure, Distributable Earnings, as defined in its filings. These reports also discuss risk factors related to lending in the cannabis industry, concentration of loans, access to financing and the implications of operating under REIT and BDC regulatory frameworks.
Current reports on Form 8-K are particularly relevant for tracking material events at Advanced Flower Capital. Recent 8-K filings have covered the announcement of quarterly financial results, shareholder votes on proposals to facilitate the conversion from a REIT to a BDC, and the adoption of a 1940 Act-compliant investment advisory agreement with AFC Management, LLC. Such filings also document the application of reduced asset coverage requirements permitted for BDCs and the effective date of the company’s conversion.
Investors can also use this page to access proxy materials such as the definitive proxy statement on Schedule 14A, which explains the rationale for the conversion to a BDC, outlines changes to the company’s investment strategy and regulatory obligations, and summarizes risks and considerations associated with the new structure. In addition, filings related to dividends, credit facilities and other financing arrangements help readers understand how Advanced Flower Capital funds and manages its senior secured loans and other debt investments.
Stock Titan’s platform supplements these documents with AI-powered summaries that highlight key points from lengthy filings, helping readers quickly identify items such as changes in leverage, updates to the investment mandate, and material developments affecting AFCG’s shareholders.
Advanced Flower Capital Inc. entered into Amendment Number Six to its existing Loan and Security Agreement originally dated April 29, 2022. In this amendment, the company remains the borrower, with the same group of lenders and the same lead arranger, bookrunner and administrative agent. The filing notes that the Sixth Amendment includes provisions that are relevant to the company’s recent conversion from a real estate investment trust to a business development company, aligning the credit agreement with its new regulatory and operating framework.
The company also reports that this amendment gives rise to a direct financial obligation or an obligation under an off-balance sheet arrangement, by cross-referencing the amended loan terms. The full text of the Sixth Amendment is filed as an exhibit, allowing readers to review the detailed changes to the loan documentation.
AFC Management, LLC, identified as an adviser to Advanced Flower Capital Inc., has filed an initial insider ownership report on Form 3. The filing indicates that the reporting person beneficially owns no securities of Advanced Flower Capital Inc., with both the non-derivative and derivative securities tables showing no holdings. The form is filed by a single reporting person and is signed by Brandon Hetzel in his capacity as Chief Financial Officer and Treasurer.
Advanced Flower Capital Inc. reported an insider purchase by a director and 10% owner. On 12/11/2025, the reporting person bought 25,000 shares of common stock at a weighted average price of $3.05 per share in open-market transactions.
After the trade, the reporting person beneficially owned 5,861,098 shares directly, 218,907 shares held by a spouse, and 180,400 shares held by the Tannenbaum Family Foundation, where the reporting person serves as President and disclaims beneficial ownership except for any pecuniary interest. The reported price reflects multiple trades executed between $3.03 and $3.10.
Advanced Flower Capital Inc. (AFCG)November 20, 2025, the director received 5,474 shares of AFCG common stock at a price of $2.74 per share. Following this transaction, the director beneficially owned 24,539 shares on a direct basis.
The filing explains that the award represents restricted stock granted under the company’s Stock Incentive Plan, and that this restricted stock was fully vested as of November 20, 2025. The form was filed for one reporting person and signed by an attorney-in-fact on the reporting person’s behalf.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for one of its directors. On November 20, 2025, the director acquired 5,474 shares of common stock as an award of restricted stock under the company’s Stock Incentive Plan. The filing notes that this restricted stock is fully vested as of November 20, 2025, meaning the director’s ownership rights are not subject to further service-based vesting conditions.
After this transaction, the director beneficially owns 9,511 shares of AFCG common stock, held directly. The transaction price reported for the award is $2.74 per share. This is a routine Form 4 disclosure showing equity-based compensation to a board member, which marginally increases insider ownership.
Advanced Flower Capital Inc. (AFCG) reported an insider equity grant to a director. On November 20, 2025, the director acquired 5,474 shares of common stock as restricted stock under the company’s Stock Incentive Plan. The filing notes this restricted stock is fully vested as of that date and was recorded at a price of $2.74 per share.
Following this grant, the director beneficially owns 9,511 shares of AFCG common stock held directly. This is a routine equity-based compensation event that modestly increases the director’s ownership stake and further aligns their interests with other shareholders.
Advanced Flower Capital Inc. (AFCG) director reported acquiring additional common stock through an equity grant. On November 20, 2025, the director received 5,474 shares of fully vested restricted stock under the company’s stock incentive plan at a price of $2.74 per share. Following this grant, the director beneficially owns 16,196 shares of AFCG common stock held directly.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its Chief Executive Officer. On 11/20/2025, the CEO acquired 91,240 shares of common stock as restricted stock granted under the company’s Stock Incentive Plan, fully vested as of that date, at a price of $2.74 per share. Following this grant, the CEO beneficially owns 317,889 shares of AFCG common stock in direct ownership. This filing is a disclosure of executive equity compensation and does not reflect an open-market purchase or sale.
Advanced Flower Capital Inc. (AFCG) reported an insider equity award for its President and CIO on a Form 4. On November 20, 2025, the executive acquired 91,240 shares of common stock as fully vested restricted stock granted under the company’s stock incentive plan at a price of $2.74 per share.
Following this transaction, the executive directly held 218,907 shares of AFCG common stock. Additional shares are reported as indirectly owned through the executive’s spouse and the Tannenbaum Family Foundation, but the executive disclaims beneficial ownership of those securities except to the extent of any pecuniary interest.
Advanced Flower Capital Inc. (AFCG) director and 10% owner reported acquiring 729,927 shares of common stock on November 20, 2025 as a fully vested restricted stock grant under the company’s stock incentive plan, at a reported price of
In addition to these directly held shares, the filing shows indirect holdings of 218,907 shares held by the reporting person’s spouse and 180,400 shares held by the Tannenbaum Family Foundation, where the reporting person serves as President. The reporting person disclaims beneficial ownership of the spouse and foundation shares except to the extent of any pecuniary interest.
FAQ
What is the current stock price of Advanced Flower Capital (AFCG)?
What is the market cap of Advanced Flower Capital (AFCG)?
